These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18479323)

  • 1. Passive ventricular restraint device with defibrillation capabilities: is there a panacea for heart failure on the horizon?
    Freedberg NA
    J Cardiovasc Electrophysiol; 2008 Aug; 19(8):858-60. PubMed ID: 18479323
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a novel ventricular support device with defibrillation capabilities in canine and porcine animal models.
    Killingsworth CR; Rippy MK; Virmani R; Rollins DL; McGiffin DC; Ideker RE
    J Cardiovasc Electrophysiol; 2008 Aug; 19(8):851-7. PubMed ID: 18373602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invited commentary.
    Mukherjee R
    Ann Thorac Surg; 2010 Jan; 89(1):137-8. PubMed ID: 20103223
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual defibrillation for refractory ventricular fibrillation in a patient with a left ventricular assist device.
    Fender E; Tripuraneni A; Henrikson CA
    J Heart Lung Transplant; 2013 Nov; 32(11):1144-5. PubMed ID: 23953919
    [No Abstract]   [Full Text] [Related]  

  • 6. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough?
    Curtis AB
    J Am Coll Cardiol; 2008 Aug; 52(7):557-8. PubMed ID: 18687250
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac assist devices: present status and future opportunities.
    Loisance D
    Expert Rev Med Devices; 2004 Sep; 1(1):43-8. PubMed ID: 16293009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological interactions between implantable cardioverter defibrillators and left ventricular assist device.
    Maffè S; Perucca A; Signorotti F; Pistono M; Paffoni P; Parravicini U; Dellavesa P; Cucchi L; Paino AM; Zenone F; Pardo NF; Bielli M; Zanetta M
    Int J Cardiol; 2010 Dec; 145(3):620-3. PubMed ID: 20965592
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantable defibrillator with left ventricular assist device compatibility.
    Oswald H; Klein G; Strüber M; Gardiwal A
    Interact Cardiovasc Thorac Surg; 2009 May; 8(5):579-80. PubMed ID: 19223309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electromagnetic interaction between an axial left ventricular assist device and an implantable cardioverter defibrillator.
    Bakhtiary F; Therapidis P; Scherer M; Dzemali O; Moritz A; Kleine P
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1380-1. PubMed ID: 19026839
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol.
    Lemke B; Lawo T; Zarse M; Lubinski A; Kreutzer U; Mueller J; Schuchert A; Mitzenheim S; Danilovic D; Deneke T;
    Europace; 2008 Aug; 10(8):907-13. PubMed ID: 18515789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epicardial and pleural lead ICD systems in children and adolescents maintain functionality over 5 years.
    Tomaske M; Prêtre R; Rahn M; Bauersfeld U
    Europace; 2008 Oct; 10(10):1152-6. PubMed ID: 18701602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A device-device interaction between a Thoratec Heartmate II left ventricular assist device and a St. Jude Atlas (V-193) implantable cardioverter defibrillator.
    Rohit M; Charles JL; Sai-Sudhakar C; Hasan AK; Chan D
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):E27; author reply E28. PubMed ID: 17887977
    [No Abstract]   [Full Text] [Related]  

  • 14. Dual implantable electronic device therapy.
    Reif S; Steiner P; Hoffmann E
    Europace; 2014 Sep; 16(9):1321. PubMed ID: 25031232
    [No Abstract]   [Full Text] [Related]  

  • 15. CPR degradation diagram.
    Geddes LA; Kemeny A; Otlewski M; Lottes AE; Taleyarkhan PR
    Cardiovasc Eng; 2009 Jun; 9(2):56-8. PubMed ID: 19533351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.
    Desai H; Aronow WS; Tsai FS; Ahn C; Lai HM; Amin H; Gandhi K; Frishman WH; Cohen M; Sorbera C
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):176-9. PubMed ID: 19617418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Part II: Sealing holes in the safety net.
    Peterson ED; Hirshfeld JW; Ferguson TB; Kramer JM; Califf RM; Kessler LG
    Am Heart J; 2004 Jun; 147(6):985-90. PubMed ID: 15199344
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment on the contribution by Lampert et al.
    Madias JE
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):E24; author reply E25. PubMed ID: 17680790
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.